|
V3333
|
(S)-4CPG
|
134052-73-6 |
S)-4CPG [also known as (S)-4-Carboxyphenylglycine, and (S)-4C-PG] is a novel, potent,competitive and orally bioactive antagonist of metabotropic glutamate receptor 1 (mGluR) withselectivity for mGluR-1 over mGluR-5. |
|
V3316
|
ARRY-797
|
1036404-17-7 |
ARRY-797 (also known as ARRY 371797) is a novel, potent and selective inhibitor of p38α (p38 mitogen-activated protein kinase). |
|
V2975
|
B-Raf IN 1
|
950736-05-7 |
B-Raf IN 1 is a novel, potent and selective B-Raf inhibitor with IC50 of 24 nM; it is equally potent against c-Raf with IC50 of 25 nM. |
|
V2989
|
BT-11
|
1912399-75-7 |
This product is discontinued due to commercial reason. |
|
V3271
|
CB-1158 analog
|
1345810-21-0 |
CB-1158 analog (CB-1158, INCB01158 or Numidargistat analog) is a potent and orally bioavailable small-molecule inhibitor of the arginase with potential immunomodulating activities. |
|
V3362
|
CP-55940 (CP 55,940)
|
83002-04-4 |
CP-55940 (CP-55,940;CP55,940) is a novel, potent and non-selective cannabinoid receptor agonist with Ki values of 0.58 and 0.69 nM for human recombinant CB1 and CB2, respectively. |
|
V3177
|
FIPI HCl
|
1781834-93-2 |
FIPI HCl, the hydrochloride salt of FIPI which is formerly known as 5-Fluoro-2-indolyl deschlorohalopemide,is a derivative of halopemide which potently and selectively inhibits both PLD1 (phospholipase D) and PLD2 with IC50values of 25 nM and 20 nM, respectively. |
|
V3197
|
GNF-6231
|
1243244-74-7 |
GNF-6231 is a novel, potent, orally active and selective Porcupine inhibitor that blocks Wnt signaling with IC50 of 0.8 nM (Wnt3a Co-culture RGA). |
|
V3291
|
GSK-962
|
2049872-86-6 |
GSK-962 (also known as GSK962 or GSK962) is a negative control for GSK963 (also known as GSK963 or GSK963). |
|
V3167
|
HDM201 R Enantiomer
|
1448867-42-2 |
HDM201 R Enantiomer is the R enantiomer of HDM201 (also called NVP-HDM201, HDM stands for human double minute 2 homolog). |
|
V2911
|
HUHS015
|
1453097-13-6 |
HUHS015 is a novel and potent inhibitor of PCA-1/ALKBH3 (prostate cancer antigen-1/AlkB Homolog 3) both in vitro and in vivo that was discovered from the optimization of a hit compound identified during random screening using a recombinant PCA-1/ALKBH3. |
|
V3040
|
JWH-133
|
259869-55-1 |
JWH-133 is a synthetic cannabinoid and a potent & selective agonist of the CB2 receptor with a Ki of 3.4nM and selectivity of ~ 200x for CB2 over CB1 receptors. |
|
V3188
|
LGD-3303
|
917891-35-1 |
LGD-3303is a potent,selective, orally bioavailable, and non-sterdoidal androgen receptor modulator (SARM) with anabolic effects on muscle and cortical bone not observed with bisphosphonates. |
|
V3259
|
Mavorixafor (AMD-070) triHCl
|
880549-30-4 |
MavorixafortriHCl (also known as AMD-1107, AMD070, X4P-001) is a potent, selective and orally bioavailable antagonist ofCXCR4 with anti-HIV activity. |
|
V3328
|
MCOPPB 3HCl
|
1108147-88-1 |
MCOPPB 3HCl is a novel and potent nonpeptide agonist of nociceptin receptor with pKi of 10.07 and may be used as an anxiolytic agent. |
|
V3220
|
ML239
|
1378872-36-6 |
ML239 was originally identified as a potent and selective inhibitor of breast cancer stem cells with an IC50of 1.16 μM, but recent studies (2016 Nature 12(2):109-16. |
|
V3235
|
ML329
|
19992-50-8 |
ML329 is a potent small molecule inhibitor ofMITF (Micropthalmia-associated transcription factor) which inhibits TRPM-1 (melastatin, a MITF target gene) promoter activity with anIC50of 1.2 μM. |
|
V3353
|
MRK-016 HCl
|
783331-24-8 |
MRK-016 HCl (MRK016; MRK 016) is a novel, potent, orally bioactive and selective negative allosteric modulator (inverse agonist) of α5 subunit-containing GABAA with nootropic properties. |
|
V3275
|
NSC23005
|
6314-70-1 |
NSC23005 is a novel and potentp18inhibitor withED50of 5.21 nM in promoting Hematopoietic stem cells (HSCs) expansion in both murine and human models. |
|
V3274
|
NSC23005 sodium
|
1796596-46-7 |
NSC23005 sodium is a novel and potentp18inhibitor withED50of 5.21 nM in promoting Hematopoietic stem cells (HSCs) expansion in both murine and human models. |